Anthracycline Versus Non-Anthracycline Induction Regimens in Patients With De Novo Acute Myeloid Leukemia

Middle East Journal of Internal Medicine
doi 10.5742/meim.2017.92935
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Medi + World International

Related search

Pre-Anthracycline Echocardiogram Rarely Changes Treatment Strategy in Acute Myeloid Leukemia

American Journal of Hematology
Hematology
2018English

Juvenile Competitive Triathlete After Cardiotoxic Anthracycline Therapy for Acute Myeloid Leukemia

Cardio-Oncology
2016English

Splicing Factor Mutations Predict Poor Prognosis in Patients With De Novo Acute Myeloid Leukemia

Oncotarget
Oncology
2016English

Downregulated Stromal Antigen 2 Expression in De Novo Acute Myeloid Leukemia Patients

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2017English

Perioperative Complications in Patients With Anthracycline Chemotherapeutic Agents

Canadian Journal of Anaesthesia
MedicineAnesthesiologyPain Medicine
1985English

De Novo Philadelphia Positive Acute Myeloid Leukemia With Extensive Basophilia: A Diagnostic Dilemma

Indian Journal of Hematology and Blood Transfusion
Hematology
2016English

Are Low-Intensity Induction Strategies Better for Older Patients With Acute Myeloid Leukemia?

Leukemia Research
Cancer ResearchOncologyHematology
2012English

Modulation of Anthracycline Resistance by Reserpine in P388 Leukemia Cells.

Folia Pharmacologica Japonica
Pharmacology
1991English

4cps-084 Anthracycline Dosage in Paediatric Obese Patients

2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy